February 17, 2021
Millions of Americans are living without power in their homes during frigid temperatures this week. Safety and security comprise the second of five facets of wellness design, and being secure in your living space is essential to your well-being. A UC expert weighs in on ways to cope.
March 2, 2021
UC's Mary Mahoney, MD, discusses how the COVID-19 vaccine could impact readings from mammograms.
October 21, 2020
Though more women are getting back on their mammogram schedules through the pandemic, alarmed cancer experts said Ohio and the nation now are caught in an unprecedented experiment with dangerous consequences.
September 30, 2020
Drug Target Review discusses findings of a study looking at the use of a naturally occurring lipid to prevent COVID-19 infection.
June 16, 2021
Rhonna Shatz, DO, discusses the spike in deaths from Alzheimer's during the pandemic on WVXU's Cincinnati Edition.
July 20, 2022
Yahoo News featured the University of Cincinnati's Jennifer Molano in an article about ways to boost your immunity during the BA.5 surge of COVID-19 cases.
June 1, 2020
Dr. Carl Fichtenbaum of the Division of Infectious Diseases at the UC College of Medicine was interviewed by CNBC on the safest ways to vacation this summer in the midst of COVID-19.
November 13, 2020
A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible allergic reactions. Yashu Dhamija, MD, a first-year fellow in the UC Division of Immunology, Allergy, and Rheumatology, presented his findings in an abstract while discussing a medically challenging case at the virtual American College of Allergy, Asthma and Immunology (ACAAI) scientific meeting held November 13-15.
February 15, 2022
The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.
August 26, 2021
Researchers at the University of Cincinnati and UC Health have administered a first-of-its-kind potential COVID-19 therapy. The first dosing was administered to a patient at UC Medical Center in Cincinnati on Aug. 17.